That's a great question. Here's what the evidence shows:

The Short Answer

The evidence for Bacillus coagulans specifically as a treatment for H. pylori is relatively weak. It has not been as well-studied for this purpose as other probiotics like Lactobacillus strains, Bifidobacterium, or Saccharomyces boulardii.

What We Know

Probiotics as a class have been studied as adjuncts (add-ons) to standard antibiotic therapy for H. pylori. Meta-analyses generally show that certain probiotics can:

• Modestly improve H. pylori eradication rates (roughly 10–15% higher)
• Significantly reduce antibiotic-related side effects (diarrhea, nausea, bloating)

However, the evidence pool is dominated by Lactobacillus spp., Bifidobacterium spp., and Saccharomyces boulardii.

Bacillus coagulans Specifically

Aspect	Assessment
Direct eradication	Very limited evidence that B. coagulans alone can eradicate H. pylori
As an adjunct to antibiotics	Some theoretical rationale (it's spore-forming so survives stomach acid, produces lactic acid which may inhibit H. pylori), but far fewer clinical trials compared to other probiotics
Side effect reduction	Plausible benefit, but the evidence base specific to B. coagulans is much thinner

Bottom Line

If you're looking to use a probiotic as an adjunct during H. pylori antibiotic treatment, the evidence is stronger for Lactobacillus-based probiotics and Saccharomyces boulardii than it is for Bacillus coagulans. While Bacillus coagulans has other well-documented digestive benefits (e.g., for IBS, antibiotic-associated diarrhea), its role in H. pylori specifically rests on a weaker evidence foundation.

Important: Probiotics are generally considered adjuncts, not replacements, for standard H. pylori antibiotic therapy. If you're dealing with an active H. pylori infection, please consult a healthcare professional for appropriate medical treatment.

Would you like me to look into product options for Bacillus coagulans or other probiotics?